Senate Approps Bill Seeks More Funds For FDA Than House
This article was originally published in The Gray Sheet
Executive Summary
The FDA device funding approved by the Senate Committee is about $8 million more than the total OK’d by the House Appropriations Committee earlier this month, but neither legislation protects industry user fees from sequestration.
You may also be interested in...
House Plan Includes No Increase For CDRH In 2014; User Fee Sequester Unresolved
A House subcommittee passed an appropriations package last week that would keep FDA device funding levels flat in fiscal 2014. The package would increase appropriations to FDA as a whole compared to 2013, but it falls short of the President’s budget request, and leaves unresolved whether 2014 user fees would be sequestered.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.